Why the study?
Although the cAMP-PKA pathway is involved in multiple cardiovascular diseases and PDE4 regulates PKA activity, whether the PDE4-cAMP-PKA pathway influences hypertension remained unknown.
Does PDE4D deficiency or inhibition prevent Ang II-induced hypertension and vascular remodeling in mice?
Population
Mice and mouse smooth muscle cells with Ang II-induced hypertension
Comparison
Knockout of Pde4d in smooth muscle cells vs control
Design
In vitro and in vivo animal experimental study
Authors
Loading...
PDE4D upregulation remains hypothesis-generating in hypertension; no clinical implications until validated in human studies.
Does PDE4D deficiency or inhibition prevent Ang II-induced hypertension and vascular remodeling in mice?
PDE4D promotes Ang II-induced hypertension via smooth muscle cell contraction, identifying PDE4 inhibitors like rolipram as potential therapeutic candidates.
Fan et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: